Tirofiban is superior to aspirin in non-obstructive strokes

Published Date: 08 Mar 2023

Results from the RESCUE BT2 trial showed that among patients with mild or major strokes, more patients taking tirofiban had better 90-day outcomes than aspirin.

Read Full News

Latest News

Global evidence highlights social roots of HPV vaccine hesitancy

Decisions about the HPV vaccine among adolescents and their families are influenced by a web of social, cultural and trust-related factors, beyond simple awareness or access, a Cochrane review finds.

Cervical cancer vaccine push has saved 1.4 million lives: Gavi

A three-year campaign to bring vaccines against human papillomavirus (HPV) to low-income countries has prevented 1.4 million cervical cancer deaths, the vaccine alliance Gavi said Monday.

Randomized trials show no evidence of non-specific vaccine effects

For more than three decades, researchers Christine Stabell Benn and Peter Aaby from the Bandim Health Project have conducted randomized trials involving thousands of children in Guinea-Bissau and Denmark to demonstrate so-called ...

Philadelphia airport passengers may have been exposed to measles, health officials warn

Passengers traveling through Philadelphia International Airport over the weekend may have been exposed to a case of the measles, city health officials warned Tuesday.

Texas whooping cough cases reach record high, data shows

Pertussis, also known as whooping cough, has reached a record high, with over 3,500 cases reported in Texas to date, according to a Texas Department of State Health Services health alert.

Biovac starts trials on South Africa's first domestically developed cholera vaccine

Researchers and scientists in South Africa on Tuesday launched clinical trials on the first domestically developed vaccine.

Todays Updates

This Week on NeurologyLive® — December 22, 2025 Isabella Ciccone, MPH

Here's some of what is coming soon to NeurologyLive® this week.

Remyelinating Agent PIPE-307 Falls Short in Phase 2 Trial of Relapsing Multiple Sclerosis Marco Meglio

Continuem's PIPE-307 trial for relapsing-remitting multiple sclerosis failed to meet primary goals, yet the company remains committed to exploring future therapies.

Brain-Penetrant Molecule GT-02287 Demonstrates Reversal of Glucosylsphinogosine in Parkinson Disease Marco Meglio

Gain Therapeutics advances Parkinson's treatment with GT 2287, showcasing promising safety and tolerability in ongoing trials. Discover the latest findings.

Daily Lemon Water Lowers Serum Urate Levels in Patients With Hyperuricemia

Daily Lemon Water Lowers Serum Urate Levels in Patients With Hyperuricemia

COPD in 2025: Year in Review

COPD in 2025: Year in Review

FDA Approves FUROSCIX On-Body Injector for Pediatric Patients, Accepts sNDA for ReadyFlow Autoinjector

FDA Approves FUROSCIX On-Body Injector for Pediatric Patients, Accepts sNDA for ReadyFlow Autoinjector

Nephrology in 2025: Year in Review

Nephrology in 2025: Year in Review

Todays Updates

This Week on NeurologyLive® — December 22, 2025 Isabella Ciccone, MPH

Here's some of what is coming soon to NeurologyLive® this week.

Remyelinating Agent PIPE-307 Falls Short in Phase 2 Trial of Relapsing Multiple Sclerosis Marco Meglio

Continuem's PIPE-307 trial for relapsing-remitting multiple sclerosis failed to meet primary goals, yet the company remains committed to exploring future therapies.

Brain-Penetrant Molecule GT-02287 Demonstrates Reversal of Glucosylsphinogosine in Parkinson Disease Marco Meglio

Gain Therapeutics advances Parkinson's treatment with GT 2287, showcasing promising safety and tolerability in ongoing trials. Discover the latest findings.

Daily Lemon Water Lowers Serum Urate Levels in Patients With Hyperuricemia

Daily Lemon Water Lowers Serum Urate Levels in Patients With Hyperuricemia

COPD in 2025: Year in Review

COPD in 2025: Year in Review

FDA Approves FUROSCIX On-Body Injector for Pediatric Patients, Accepts sNDA for ReadyFlow Autoinjector

FDA Approves FUROSCIX On-Body Injector for Pediatric Patients, Accepts sNDA for ReadyFlow Autoinjector

Nephrology in 2025: Year in Review

Nephrology in 2025: Year in Review

Latest News

Decisions about the HPV vaccine among adolescents and their families are influenced by a web of social, cultural and trust-related factors, beyond simple awareness or access, a Cochrane review finds.

A three-year campaign to bring vaccines against human papillomavirus (HPV) to low-income countries has prevented 1.4 million cervical cancer deaths, the vaccine alliance Gavi said Monday.

For more than three decades, researchers Christine Stabell Benn and Peter Aaby from the Bandim Health Project have conducted randomized trials involving thousands of children in Guinea-Bissau and Denmark to demonstrate so-called ...

Passengers traveling through Philadelphia International Airport over the weekend may have been exposed to a case of the measles, city health officials warned Tuesday.

Pertussis, also known as whooping cough, has reached a record high, with over 3,500 cases reported in Texas to date, according to a Texas Department of State Health Services health alert.

Researchers and scientists in South Africa on Tuesday launched clinical trials on the first domestically developed vaccine.

News All Time

California partnership aided COVID-19 response and health equity, report finds

The COVID-19 pandemic did not affect everyone equally. Communities of color, especially Latino (including undocumented persons), Black, and Native American groups, as well as people with low incomes, experienced much higher ...

CDC stops recommending COVID-19 shots for all, leaves decision to patients

The Centers for Disease Control and Prevention adopted recommendations by a new group of vaccine advisers, and stopped recommending COVID-19 shots for anyone—leaving the choice up to patients.

Study: Flu vaccine uptake consistently highest for Asian patients, lowest for Black patients

Persistent racial differences in flu vaccination uptake are seen across ages and flu seasons, according to a study published in the Oct. 3 issue of Vaccine.

A middle-ground framework for US vaccine policy

In a new JAMA Viewpoint, Lainie Friedman Ross, MD, Ph.D., chair of the Department of Health Humanities and Bioethics at the University of Rochester Medical Center, and Mark Navin, Ph.D., chair of Philosophy at Oakland University, ...

Opinion: Experts warn disaster looms following politicized US health changes

Authors from the American College of Physicians (ACP) warn that disaster looms ahead for the U.S. health care system, likely precipitated by an epidemic of vaccine-preventable and attenuating diseases. They say the politicization ...

RSV vaccine uptake in pregnancy linked to perinatal outcomes and health inequities

Uptake of the respiratory syncytial virus (RSV) vaccine during pregnancy is not linked to increased risk of adverse perinatal health outcomes among vaccinated women, according to research at City St George's and published ...

Chickenpox: Why the UK has approved the MMRV vaccine in under-fours but the US is preparing to restrict it

Two countries, two different approaches to protecting children from chickenpox. While the UK prepares to introduce a combined vaccine covering measles, mumps, rubella and chickenpox (MMRV) in a single jab, the US is moving ...

Despite escalating anti-vaccine rhetoric, most Americans support vaccine mandates, surveys find

At an explosive news conference on the causes of autism, President Donald Trump espoused decades-old, long-debunked theories linking autism to the childhood vaccine schedule.

Minnesota defies feds with COVID vaccine guidance

Minnesota's top doctor issued a standing order on Sept. 22 allowing pharmacists to give COVID-19 vaccines without prescriptions to a broader group of patients than federally recommended.

New vaccine panel recommends doctor consults before COVID shots

A new federal vaccine panel appointed by U.S. Health Secretary Robert F. Kennedy Jr. has recommended tighter restrictions on COVID-19 shots.

Vaccine mandates misinformation: Two experts explain the true role of slavery and racism

On Sept. 3, 2025, Florida announced its plans to be the first state to eliminate vaccine mandates for its citizens, including those for children to attend school.

Take the shot: Does the country's future hang on public health support?

The Advisory Committee on Immunization Practices recently linked 25 unverified reports of child deaths to COVID-19 vaccines as they consider further limiting access to this and other immunizations, like those for hepatitis ...

Illinois committee recommends state part ways with feds on COVID-19 vaccines

Illinois health leaders should part ways with the federal government when it comes to COVID-19 vaccines and recommend the shots for all adults and many children, an influential state committee voted Monday.

CDC advisers limit MMRV combo vaccine, delay hepatitis B vote

Top vaccine advisers hand-selected by Health Secretary Robert F. Kennedy Jr. voted Thursday to limit the use of a combination shot that protects against measles, mumps, rubella and chickenpox.

West Coast states issue their own COVID, flu, RSV vaccine rules

Four Western states are taking a different approach from the U.S. Centers for Disease Control and Prevention (CDC) on vaccines for COVID-19, flu and RSV.

US vaccine panel to hold high-stakes policy meeting

A US panel stacked with figures sympathetic to the anti-vaccine movement will on Thursday take on federal immunization recommendations in a highly politicized meeting that could upend longstanding medical advice.

Recommended News For You

For cancer patients who are not responding to chemotherapy, new genes and natural toxins offer hope.

In cancer patients taking immune checkpoint inhibitors, systematic vitamin D supplementation improves outcomes.

Researchers find distinct cell receptors with the potential for new treatments.

A study suggests that screening for liver cancer is beneficial for patients with cirrhosis.

New Zealand and Australian breast cancer rates among the highest in the world, global study finds

Five-year survival in patients with unresectable hepatocellular carcinoma sets milestone

Studies have shown that physical activity prevents cancer in patients who have been treated for cancer in the past.

Recommended Articles For You

Colorectal Cancer Incidence Trends: A Growing Concern in 2024 and 2025 

Symptoms and Causes of Phlegmasia Cerulea Dolens: A Comprehensive Guide  

Understanding the Importance of Knowing Your MCV Normal Range 

Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Upfront TKI for Bone-Predominant RCC Tops Single-Agent Immunotherapy

2.

TikTok creators perform 'roles' when sharing their hereditary cancer stories, shaping the health information they share

3.

Novel probes to label macrophages associated with cancer progression using a selective dye

4.

Study finds 20 minutes of mindful breathing can rapidly reduce intensity of cancer pain

5.

A prostate cancer risk prediction algorithm could help target men at highest risk

1.

Targeting Oncology: Expanding Combinatorial Strategies by 2025

2.

Demystifying the Mentzer Index: Understanding Its Importance in Inventory Management 

3.

Colon Cancer Staging: What You Need to Know

4.

Pharmacological Frontier of Precision Oncology, Immunotherapies, and the Evolving Art of Treatment

5.

Florinef: Understanding Its Uses and Side Effects 

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks

2.

Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer

3.

Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment

4.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC

5.

Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot